Leave of Absence Agreement between ContraFect Corporation and Steven C. Gilman, Ph.D. (March 2017)
ContraFect Corporation and Dr. Steven C. Gilman have agreed that Dr. Gilman will take a medical leave of absence from his role as Chief Executive Officer starting March 16, 2017. During this leave, which may last up to six months or until his return or employment termination, he will be excused from CEO duties but will continue as Chairman of the Board. He will receive 50% of his base salary and maintain health and welfare benefits for himself and his family. This arrangement does not qualify as "Good Reason" for resignation under his prior agreement.
Exhibit 10.1
March 10,2017 | 28 Wells Avenue, Third Floor | |
Yonkers, New York 10701 | ||
Steven C. Gilman, Ph.D. | 914 ###-###-#### tel | |
527 Concord Street | 914 ###-###-#### fax | |
Belmont, MA 02478 | WWW.CONTRAFECT.COM |
Dear Dr. Gilman,
As discussed, set forth below is a summary of our mutual agreement regarding certain terms of your leave of absence from active employment with ContraFect Corporation (the Company) for medical reasons beginning on March 16, 2017 (the Leave Start Date).
During the period commencing on the Leave Start Date and ending on the earliest of: (i) the date that is six months following the Leave Start Date; (ii) your return to active employment with the Company; or (iii) the termination of your employment with the Company (the Leave Period), you will be excused from performing your duties as Chief Executive Officer of the Company but are expected to continue performing your duties as Chairman of the Companys Board of Directors. During the Leave Period, you will receive a base salary at a rate equal to 50% of your base salary in effect as of the Leave Start Date, paid in accordance with the Companys ordinary payroll practices and subject to tax withholdings required by law, and you, your spouse and your eligible dependents will continue to be eligible to participate in the Companys health and welfare benefit plans as provided in the letter agreement between you and the Company, dated July 21, 2016.
The foregoing will not provide a basis for you to resign your employment for Good Reason under the letter agreement between you and the Company, dated July 21, 2016.
Please indicate your agreement to the foregoing by returning a countersigned copy of this letter to me.
Sincerely, |
|
Sol J. Barer, Ph.D. |
Lead Independent Director |
Accepted and agreed: |
|
Steven C. Gilman, Ph.D. |